295 Doxycycline can inhibit
matrix metalloproteinases in plasma and aneurysm tissue and thus has been proposed as an agent to limit
AAA growth.296,297 However, a randomized trial of
low-dose doxycycline (100 mg once daily) demonstrated
no reduction in aneurysm growth during an 18-month
period.298 An ongoing National Institutes of Health trial
is examining